The Clinico-Pathologic Role of MicroRNAs miR-9 and miR-151-5p in Breast Cancer Metastasis

Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006 Nov 17; 127 (4): 679–95.

Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002 Jun; 2 (6): 442–54.

Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 2003 Jun; 3 (6): 453–8.

Ma L, Weinberg RA. Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet 2008 Sep; 24 (9): 448–56.

Nicoloso MS, Spizzo R, Shimizu M, et al. MicroRNAs: the micro steering wheel of tumour metastases. Nat Rev Cancer 2009 Apr; 9 (4): 293–302.

Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 Jan 23; 116 (2): 281–97.

Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009 Jan 23; 136 (2): 215–33.

Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004 Mar 2; 101 (9): 2999–3004.

Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009 Feb 20; 136 (4): 586–91.

Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006 Nov; 6 (11): 857–66.

Castellano L, Giamas G, Jacob J, et al. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci U S A 2009 Sep 15; 106 (37): 15732–7.

Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007 Oct 11; 449 (7163): 682–8.

Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005 Aug 15; 65 (16): 7065–70.

Ma L, Young J, Prabhala H, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010 Mar; 12 (3): 247–56.

Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human micro RNAs that suppress breast cancer metastasis. Nature 2008 Jan 10; 451 (7175): 147–52.

Valastyan S, Reinhardt F, Benaich N, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009 Jun 12; 137 (6): 1032–46.

Lujambio A, Calin GA, Villanueva A, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 2008 Sep 9; 105 (36): 13556–61.

Luedde T. MicroRNA-151 and its hosting gene FAK (focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma. Hepatology 2010 Sep; 52 (3): 1164–6.

Loudig O, Milova E, Brandwein-Gensler M, et al. Molecular restoration of archived transcriptional profiles by complementary-template reverse-transcription (CT-RT). Nucleic Acids Res 2007; 35 (15): e94.

Enerly E, Steinfeld I, Kleivi K, et al. miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 2011; 6 (2): e16915.

Buffa FM, Camps C, Winchester L, et al. microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res 2011 Sep 1; 71 (17): 5635–45.

Schultz NA, Werner J, Willenbrock H, et al. MicroRNA expression profiles associated with pancreatic cancer [abstract]. J Clin Oncol 2011 Feb 1; 29 (4 Suppl.): abstract 153.

Finak G, Bertos N, Pepin F, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008; 14 (5): 518–27.

Walker RA, Bartlett JM, Dowsett M, et al. HER2 testing in the UK: further update to recommendations. J Clin Pathol 2008 Jul; 61 (7): 818–24.

Sieuwerts AM, Mostert B, Bolt-de Vries J, et al. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin Cancer Res 2011 Jun 1; 17 (11): 3600–18.

Shaw JA, Brown J, Coombes RC, et al. Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer. Biomark Med 2011 Feb; 5 (1): 87–91.

Gu Y, Lin S, Li JL, et al. Altered LKB1/CREB-regulated transcription coactivator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion. Oncogene 2012 Jan 26; 31 (4): 469–79.

Tognon CE, Somasiri AM, Evdokimova VE, et al. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway. Cancer Res 2011 Feb 1; 71 (3): 1060–70.

Wendt MK, Schiemann WP. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Breast Cancer Res 2009; 11 (5): R68.

Acs G, Lawton TJ, Rebbeck TR, et al. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001 Jan; 115 (1): 85–98.

Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993 Apr; 142 (4): 987–93.